Cargando…
Characteristic interactivity of landiolol, an ultra-short-acting highly selective β(1)-blocker, with biomimetic membranes: Comparisons with β(1)-selective esmolol and non-selective propranolol and alprenolol
Although β(1)-blockers have been perioperatively used to reduce the cardiac disorders associated with general anesthesia, little is known about the mechanistic characteristics of ultra-short-acting highly selective β(1)-blocker landiolol. We studied its membrane-interacting property in comparison wi...
Autores principales: | Tsuchiya, Hironori, Mizogami, Maki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857573/ https://www.ncbi.nlm.nih.gov/pubmed/24339816 http://dx.doi.org/10.3389/fphar.2013.00150 |
Ejemplares similares
-
Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
por: Wada, Yuko, et al.
Publicado: (2016) -
Dose-dependent scavenging activity of the ultra-short-acting β1-blocker landiolol against specific free radicals
por: Matsumoto, Shigekiyo, et al.
Publicado: (2022) -
Dose-Dependent Effect of Landiolol, a New Ultra-Short-Acting β(1)-Blocker, on Supraventricular Tachyarrhythmias in Postoperative Patients
por: Taenaka, Nobuyuki, et al.
Publicado: (2013) -
Landiolol, an intravenous β1‐selective blocker, is useful for dissociating a fusion of atrial activation via accessory pathway and atrioventricular node
por: Kinjo, Takahiko, et al.
Publicado: (2023) -
Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprolol
por: Borowiecki, Paweł, et al.
Publicado: (2022)